Hypera SA is a pharmaceutical company, which engages in the manufacture and distribution of medical and cosmetics products. The company is headquartered in Sao Paulo, Sao Paulo. The company went IPO on 2008-04-16. The firm operates in several markets with a variety of pharmaceutical products. The firm's products include: Mantecorp Farmasa, which is an under the umbrella brand; Addera D3, Nesina, Dramin, Alivium, Predsim, Lisador, and Rinosoro, which focus on several medical specialties involving primary care which are present in main therapeutic classes; Mantecorp Skincare, which offer dermo cosmetics recommended by dermatologists and also operates in this segment with the brands Simple Organic, which offers organic, vegan, and cruelty-free products, and Bioage, which focuses on the professional aesthetic treatment market; and Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina, which are over-the-counter medications provided throughout Brazil.
Mr. Breno Toledo De Oliveira es el Chief Executive Officer de Hypera S.A., se unió a la empresa desde 2011.
¿Qué tal es el rendimiento del precio de la acción Hypera SA?
El precio actual de Hypera SA es de $0, ha disminuido un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Hypera S.A.?
Hypera S.A. pertenece a la industria Pharmaceuticals y el sector es Health Care
¿Cuál es la capitalización bursátil de Hypera S.A.?
La capitalización bursátil actual de Hypera S.A. es $2.7B
¿Es Hypera S.A. una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 13 analistas han realizado calificaciones de análisis para Hypera S.A., incluyendo 4 fuerte compra, 9 compra, 7 mantener, 0 venta, y 4 fuerte venta